Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Skin irritation
RhE, OECD439, GLP, negative
Eye irritation
RhCE, OECD 492, GLP, positive
mixture rule calculation, 7.5 % manganese (Eye damage Cat 1) in registered substance, C&L as Eye damage Cat 1
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 Feb 2021 to ... July 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- adopted 26. Jun. 2020
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- adopted 06. Jul. 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Landesamt für Umwelt Rheinland-Pfalz 15 May 2018
- Test system:
- human skin model
- Remarks:
- commercially available EpiDermTM-Kit, procured by MatTek
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: human-derived epidermal keratinocytes which have been cultured to form a multi-layered, highly differentiated model of the human epidermis.
- Details on animal used as source of test system:
- not applicable
- Justification for test system used:
- This in vitro study was performed in order to evaluate the potential of "manganese-EDDHA sodium salts" to evoke skin irritation in a Reconstructed human Epidermis (RhE) test method.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RhE) TISSUE
- Model used:
EpiDermTM-Kit, procured by MatTek
- Designation of the kit:
1) EPI-200-SIT
2) EPI-218_SIT
- Tissue batch number(s):
1) 34134
2) 34162
- Delivery date:
1) 2021 March 16
2) 2021 May 25
- Date of initiation of testing:
2021 March
- Date of experimantal completion
2021 March
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 35 minutes at 37 ± 1°C and 5.0 ± 1% CO2 and ≥ 95% relative humidity and 25 min at room temperature
- Temperature of post-treatment incubation (if applicable): 37 ± 1 °C and 5.0 ± 1% CO2 and ≥ 95% relative humidity
REMOVAL OF TEST MATERIAL AND CONTROLS
1 hour after the first application, the inserts were removed from the plates using sterile forceps and rinsed immediately in 1-minute-intervals.
After rinsing thoroughly with DPBS, each tissue was blotted with sterile cellulose tissue and then transferred into a new 6-well-plate with fresh assay medium (0.9 mL). The surface of the inserts was then carefully dried with a sterile cotton tipped swab.
Then, the tissues were set in the incubator for 24 hours at 37 ± 1°C and 5.0 ± 1% CO2 and ≥ 95% relative humidity.
After incubation the tissues were removed from the incubator and shaken for 5 minutes (120 rpm). 0.9 mL assay medium were filled in the lower row of the 6-well-plate. Then the inserts were transferred into the lower row of the 6-well-plate and set into the incubator for 19 hours and 40 minutes in the main test and 18 hours in the additional test for post-incubation at 37 ± 1°C and 5.0 ± 1% CO2 and ≥ 95% relative humidity.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 3 h
- Spectrophotometer: Microtiter plate photometer Anthos Reader 2010 Flexi (Anthos Microsysteme GmbH)
- Wavelength: 570 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
Batch 34134
- Viability: MTT QC assay, 4 hours, n=3 -> OD=1.624 ± 0.135 (range 1 - 3 -> passed)
- Barrier function: ET50 assay (1 % Triton) -> ET50=4.84 h (range 4.77 - 8.72 h -> passed)
- Contamination: no contamination
Batch 34162
- Viability: MTT QC assay, 4 hours, n=3 -> OD=1.57 ± 0.047 (range 1 - 3 -> passed)
- Barrier function: ET50 assay (1 % Triton) -> ET50=6.28 h (range 4.77 - 8.72 h -> passed)
- Contamination: no contamination
NUMBER OF REPLICATE TISSUES:
3
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
- Fresh tissues
- N. of replicates : 2
- Method of calculation used: Viability treated tissue (corrected) = Viability treated tissue (main test) – Viability treated tissue (additional test, no MTT assay)
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
1
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be irritating to skin if the viability after 60 minutes exposure is less than or equal to 50%
- The test substance is considered to be non-irritating to skin if the viability after 60 minutes exposure is greater than 50% - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
main test 26.3; 25.9; 26.3 mg
additional test 26.1; 25.9 mg
VEHICLE
no vehicle used
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL [“Dulbecco’s Phosphate Buffered Saline” (DPBS buffer without CaCl2 and without MgCl2)]
- Concentration (if solution): 100 %
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL [SDS-solution]
- Concentration (if solution): 5 % - Duration of treatment / exposure:
- 60 min
- Duration of post-treatment incubation (if applicable):
- 43 hours and 40 minutes in the main test and 42 hours in the additional test
- Number of replicates:
- 3 (main test), 2 (additional test)
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 1
- Value:
- 91.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 2
- Value:
- 90.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3
- Value:
- 80.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- mean
- Value:
- 87.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Acceptance criteria met for variability between replicate measurements: yes
All validity criteria were met.
The values for negative control and for positive control were within the range of historical data of the test facility - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item Manganese-EDDHA sodium salts is considered as not irritant to skin. After the treatment, the mean value of relative tissue viability was 87.3 %. This value is well above the threshold for skin irritation (50%). The optical density of the negative control was well within the required acceptability criterion of 0.8 ≤ mean OD ≤ 2.8. The positive control has met the acceptance criterion too, for thus ensuring the validity of the test system. The variation within replicates was within the accepted range for negative control, positive control and test item (required: ≤ 18%). For these reasons, the result of the test is considered valid.
- Executive summary:
One valid experiment was performed according to OECD Guideline 439 following GLP with three tissues and two independent MTT measurements. Three tissues of the human skin model EpiDermTM were treated with the test item for 60 minutes. The test item was applied directly to each tissue and spread to match the tissue size (0.63 cm²; as indicated by the supplier). DPBS-buffer was used as negative control and 5% SDS solution was used as positive control. After treatment with the negative control, the mean absorbance value was within the required acceptability criterion of 0.8 ≤ mean OD ≤ 2.8, OD was 1.653. The positive control showed clear irritating effects. The mean value of relative tissue viability was reduced to 2.8% (required: ≤ 20%). The variation within the tissue replicates of negative control, positive control and test item was acceptable (required: ≤ 18%). After the treatment with the test item, the mean value of relative tissue viability was 87.3%. This value is well above the threshold for skin irritation potential (50%). Thus, the test item Manganese-EDDHA sodium salts is considered as not irritant to skin. As the test item showed intense coloring in the pre-test, there was the risk to influence the photometric measurement and create a false negative result. Therefore, an additional test for intensely coloured test items was performed.The result of the valid additional test showed, that the test item colour did not critically influence the result of the study and no data correction is necessary.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 FEB 2021 - 2 JUN 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted 18. Jun. 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Landesamt für Umwelt Rheinland-Pfalz 15 May 2018
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method (e.g. ICE, EIT, RhCE) and considerations regarding applicability:
This study was performed in order to evaluate the eye hazard potential of ManganeseEDDHA sodium salts in a Reconstructed human Cornea-like Epithelium (RhCE) model in an in vitro study (e.g. EpiOcular™ Eye Irritation Test). The EpiOcular™ Eye Irritation Test (EIT) predicts the acute eye hazard potential of chemicals by measurement of tissue damage caused by cytotoxic effects in the reconstructed human cornea-like tissue model. Within a testing strategy, the EpiOcular™ EIT can be used as a replacement of the in vivo Draize Eye Irritation Test. It is utilized for the classification and labelling of chemicals concerning their eye hazard potential. The EpiOcular™ EIT can be used to identify chemicals that do not require classification for eye irritation or serious eye damage according to the UN GHS classification system. A limitation of this guideline is that it neither allows discrimination between eye irritation/reversible effects on the eye (Category 2) and serious eye damage/irreversible effects on the eye (Category 1), nor between eye irritants (optional Category 2A) and mild eye irritants (optional Category 2B). For these purposes, further testing with other suitable test methods is required The solid test item was applied topically to a three-dimensional RhCE tissue construct in duplicate for an exposure time of 6 hours. Eye hazard materials are identified by their ability to produce a decrease in cell viability as determined. The cell viability is measured by dehydrogenase conversion of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide), present in cell mitochondria, into a blue formazan salt that is quantitatively measured after extraction from tissues. The percentage reduction of cell viability in comparison of untreated negative controls is used to predict the eye irritation potential. The test substance falls within the applicaility domain of this model.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live: No bacteria, yeast and other fungi were detected, Tissue viability and Barrier function were within the acceptance criteria
- Cell line used, its source, passage number and confluence of cells used for testing: Keratinocyte strain 4F1188
- RhCE tissue or hCE cell construct used, including batch number: EpiOcular™ Tissue (Lot No. 34901) - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 mg - Duration of treatment / exposure:
- 6 h
- Duration of post- treatment incubation (in vitro):
- 18 h
- Number of animals or in vitro replicates:
- 2
- Details on study design:
- - Details of the test procedure used
:
The solid test item was applied topically to a three-dimensional RhCE tissue construct in duplicate for an exposure time of 6 hours. Eye hazard materials are identified by their ability to produce a decrease in cell viability as determined. The cell viability is measured by dehydrogenase conversion of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide), present in cell mitochondria, into a blue formazan salt that is quantitatively measured after extraction from tissues. The percentage reduction of cell viability in comparison of untreated negative controls is used to predict the eye irritation potential
- Doses of test chemical and control substances used :
test item: 50 mg, positive and negative control: 50 µL
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable) : 6 h exposure 37 ± 1 °C, 18 h post-exposure incubation at 37 ± 1 °C
- Number of tissue replicates used per test chemical and controls (positive control, negative control) : 2
- For hCE cells: number of runs and of hCE models used within each run : 1 run, 2 tissues per test item/controls
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer) : 570 nm
- Description of the method used to quantify MTT formazan, if applicable : The inserts were removed from the 6-well plate and discarded. 1 mL isopropanol was added and the content of each well was thoroughly mixed in order to achieve homogenisation.
From each well, two replicates with 200 µL solution (each) were pipetted into a 96-wellplate. The plate was read in a plate spectrophotometer at 570 nm. In addition, eight wells of the 96-well-plate were filled with 200 µL isopropanol each, serving as blank
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model : according to OECD TG 492
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria :
negative control OD: historical range 1.047 - 2.340 (mean 1.660) - study 1.618
positive control viability: historical range 20.4 - 47.8% (mean 34.1%) - study 26.4%
- Complete supporting information for the specific RhCE tissue construct or hCE cells used :
EpiOcular™ tissues were procured from MatTek In Vitro Life Science Laboratories, Mlynské Nivy 73, 82105 Bratislava, Slovakia.
Designation of the kit: OCL-200-EIT
Day of delivery: 16. Mar. 2021
Batch no.: 34901
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals : All 15 proficiency chemicals of the OECD TG 492 were correctly classified.
- Acceptable variability between tissue replicates for positive and negative controls : <20%
- Acceptable variability between tissue replicates for the test chemical: <20% - Irritation parameter:
- percent tissue viability
- Run / experiment:
- Tissue 1
- Value:
- 1.1
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- percent tissue viability
- Run / experiment:
- Tissue 2
- Value:
- 1.2
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
The pre-test showed, that the test item was intensely coloured (OD > 0.08), but the mean viability of the tissues treated with test item was 1.2% (≤ 60%) and therefore the additional test was not necessary.
DEMONSTRATION OF TECHNICAL PROFICIENCY: demonstrated on the 15 proficiency chemicals indicated in the OECD TG 492
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: demanded OD > 0.8 < 2.8 - found OD 1.618
- Acceptance criteria met for positive control: demanded < 50 % of negative control - found 26.4 % - Interpretation of results:
- study cannot be used for classification
- Conclusions:
- After treatment with the test item, the mean value of relative tissue viability was 1.2%. This value is below the threshold for eye irritation potential (≤ 60%). Test items that induce values below the threshold are considered either eye irritant or inducing serious eye damage.
- Executive summary:
The registered substance was tested for eye irritation in a GLP compliant in vitro study according to OECD Guideline 492. The test item was applied to a three-dimensional human cornea tissue model in duplicate for an exposure time of 6 hours. The solid test item was applied to two tissue replicates. After treatment, the respective substance was rinsed from the tissue; then, cell viability of the tissues was evaluated by addition of MTT, which can be reduced to formazan. The formazan production was evaluated by measuring the optical density (OD) of the resulting solution. Demineralised water was used as negative control and methyl acetate was used as positive control. The controls showed the following results: After treatment with the negative control, the absorbance values were within the required acceptability criterion of mean OD > 0.8 and < 2.8, OD was 1.618. The positive control showed clear eye irritating effects, the mean value of the relative tissue viability was 26.4% (< 50%). The variation within tissue replicates of the controls and the test item was acceptable (< 20%). After treatment with the test item, the mean value of relative tissue viability was 1.2%. This value is below the threshold for eye irritation potential (≤ 60%). Test items that induce values below the threshold are considered either eye irritant or inducing serious eye damage. According to the OECD Guideline 492, the EpiOcular™ Eye Irritation Test does not allow discrimination between eye irritation/reversible effects on the eye (Category 2) and serious eye damage/irreversible effects on the eye (Category 1). In this case no prediction can be made and further testing with other suitable test methods is required. Under the conditions of the test, Manganese-EDDHA sodium salts is considered either eye irritant or inducing serious eye damage in the EpiOcularTM Eye Irritation Test.
- Endpoint:
- eye irritation, other
- Remarks:
- classification based on mixture rules calculation
- Type of information:
- mixture rules calculation
- Adequacy of study:
- supporting study
- Interpretation of results:
- Category 1 (irreversible effects on the eye) based on GHS criteria
- Conclusions:
- The registered substance contains manganese at a concentration of 7.5 %. Thus, it is classified as Eye damage Cat 1 (H318) according to Regulation (EC) No 1272/2008.
- Executive summary:
In the ECHA disseminated dossiers the two manganese salts MnSO4 and MnCl2, which serve also as source substances for read-across are classified as Eye damage Cat 1 (H318). Based on the rules on classification for mixtures as specified in Regulation (EC) No 1272/2008 (Table 3.3.3), the threshold for classification of a mixture as Eye damage Cat 1 is a concentration of ≥ 3 % of a constituent classified as Eye damage Cat 1. The registered substance contains manganese at a concentration of 7.5 %. Thus, it is classified as Eye damage Cat 1 (H318).
Referenceopen allclose all
Table 1: Absorbance Values Negative Control, Positive Control and Test Item (OD at 570 nm)
Designation |
Measurement |
Negative Control |
Positive Control |
Test Item |
Tissue 1 |
1 |
1.740 |
0.442 |
0.052 |
2 |
1.750 |
0.443 |
0.052 |
|
Tissue 2 |
1 |
1.561 |
0.479 |
0.054 |
2 |
1.558 |
0.482 |
0.054 |
Table 2: Mean Absorbance Negative Control, Positive Control and Test Item
Designation |
Negative Control |
Positive Control |
Test Item |
Mean – blank (Tissue 1) |
1.711 |
0.409 |
0.018 |
Mean – blank (Tissue 2) |
1.526 |
0.447 |
0.020 |
Table 3: % Viability Positive Control and Test Item
Designation |
Positive Control |
Test Item |
% Viability (Tissue 1) |
25.2% |
1.1% |
% Viability (Tissue 2) |
27.6% |
1.2% |
% Viability Mean |
26.4% |
1.2% |
In the ECHA disseminated dossiers the two manganese salts MnSO4 and MnCl2, which serve also as source substances for read-across are classified as Eye damage Cat 1 (H318). Based on the rules on classification for mixtures as specified in Regulation (EC) No 1272/2008 (Table 3.3.3), the threshold for classification of a mixture as Eye damage Cat 1 is a concentration of ≥ 3 % of a constituent classified as Eye damage Cat 1. The registered substance contains manganese at a concentration of 7.5 %. Thus, it is classified as Eye damage Cat 1 (H318).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irreversible damage)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritaion
OECD 439
One valid experiment was performed according to OECD Guideline 439 following GLP with three tissues and two independent MTT measurements. Three tissues of the human skin model EpiDermTM were treated with the test item for 60 minutes. The test item was applied directly to each tissue and spread to match the tissue size (0.63 cm²; as indicated by the supplier). DPBS-buffer was used as negative control and 5% SDS solution was used as positive control. After treatment with the negative control, the mean absorbance value was within the required acceptability criterion of 0.8 ≤ mean OD ≤ 2.8, OD was 1.653. The positive control showed clear irritating effects. The mean value of relative tissue viability was reduced to 2.8% (required: ≤ 20%). The variation within the tissue replicates of negative control, positive control and test item was acceptable (required: ≤ 18%). After the treatment with the test item, the mean value of relative tissue viability was 87.3%. This value is well above the threshold for skin irritation potential (50%). Thus, the test item Manganese-EDDHA sodium salts is considered as not irritant to skin. As the test item showed intense coloring in the pre-test, there was the risk to influence the photometric measurement and create a false negative result. Therefore, an additional test for intensely coloured test items was performed.The result of the valid additional test showed, that the test item colour did not critically influence the result of the study and no data correction is necessary.
Eye irritation
OECD 492
The registered substance was tested for eye irritation in a GLP compliant in vitro study according to OECD Guideline 492. The test item was applied to a three-dimensional human cornea tissue model in duplicate for an exposure time of 6 hours. The solid test item was applied to two tissue replicates. After treatment, the respective substance was rinsed from the tissue; then, cell viability of the tissues was evaluated by addition of MTT, which can be reduced to formazan. The formazan production was evaluated by measuring the optical density (OD) of the resulting solution. Demineralised water was used as negative control and methyl acetate was used as positive control. The controls showed the following results: After treatment with the negative control, the absorbance values were within the required acceptability criterion of mean OD > 0.8 and < 2.8, OD was 1.618. The positive control showed clear eye irritating effects, the mean value of the relative tissue viability was 26.4% (< 50%). The variation within tissue replicates of the controls and the test item was acceptable (< 20%). After treatment with the test item, the mean value of relative tissue viability was 1.2%. This value is below the threshold for eye irritation potential (≤ 60%). Test items that induce values below the threshold are considered either eye irritant or inducing serious eye damage. According to the OECD Guideline 492, the EpiOcularTM Eye Irritation Test does not allow discrimination between eye irritation/reversible effects on the eye (Category 2) and serious eye damage/irreversible effects on the eye (Category 1). In this case no prediction can be made and further testing with other suitable test methods is required. Under the conditions of the test, Manganese-EDDHA sodium salts is considered either eye irritant or inducing serious eye damage in the EpiOcularTM Eye Irritation Test.
Mixture rule calculation
In the ECHA disseminated dossiers the two manganese salts MnSO4 and MnCl2, which serve also as source substances for read-across are classified as Eye damage Cat 1 (H318). Based on the rules on classification for mixtures as specified in Regulation (EC) No 1272/2008 (Table 3.3.3), the threshold for classification of a mixture as Eye damage Cat 1 is a concentration of ≥ 3 % of a constituent classified as Eye damage Cat 1. The registered substance contains manganese at a concentration of 7.5 %. Thus, it is classified as Eye damage Cat 1 (H318).
Justification for classification or non-classification
Based on the available information the registered substance is classified as Eye damage Cat 1 (H318).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)